The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
1.460
+0.045 (3.18%)
Dec 20, 2024, 4:00 PM EST - Market closed
The Beauty Health Company Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SKIN stock have an average target of 2.55, with a low estimate of 1.00 and a high estimate of 5.00. The average target predicts an increase of 74.66% from the current stock price of 1.46.
Analyst Consensus: Hold
* Price targets were last updated on Nov 13, 2024.
Analyst Ratings
The average analyst rating for SKIN stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 6 | 6 | 3 |
| Sell | 3 | 3 | 3 | 3 | 3 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 10 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.25 → $1.75 | Hold | Maintains | $1.25 → $1.75 | +19.86% | Nov 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -14.38% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Sell Reiterates $1.5 → $1 | Sell | Reiterates | $1.5 → $1 | -31.51% | Aug 9, 2024 |
| Stifel | Stifel | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +36.99% | Jul 26, 2024 |
| Piper Sandler | Piper Sandler | Sell Maintains $2.5 → $1.5 | Sell | Maintains | $2.5 → $1.5 | +2.74% | Jul 11, 2024 |
Financial Forecast
Revenue This Year
334.78M
from 397.99M
Decreased by -15.88%
Revenue Next Year
341.69M
from 334.78M
Increased by 2.06%
EPS This Year
-0.26
from -0.76
EPS Next Year
-0.26
from -0.26
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 348.4M | 370.3M | 415.3M | |
| Avg | 334.8M | 341.7M | 385.3M | |
| Low | 319.1M | 283.8M | 352.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -12.5% | 10.6% | 21.5% | |
| Avg | -15.9% | 2.1% | 12.7% | |
| Low | -19.8% | -15.2% | 3.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.22 | -0.11 | -0.03 |
| Avg | -0.26 | -0.26 | -0.17 |
| Low | -0.35 | -0.42 | -0.28 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.